Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement

Rituximab for ANCA-Associated Vasculitis Immune Tolerance Network Research Group

Research output: Contribution to journalArticlepeer-review

66 Scopus citations

Fingerprint

Dive into the research topics of 'Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement'. Together they form a unique fingerprint.

Medicine & Life Sciences